OakChart

Bright Minds Biosciences Inc

DRUGHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 1:24 PM ET

22.14-0.47 (-2.08%)
2026-11-11 19:24 CET
Market cap
223.03 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-17.75 USD m
Free cash flow, TTM
-17.86 USD m
EPS diluted, TTM
-2.08
P/E
-
Compare

Price

DRUG against its 20, 50 and 200-day averages
2050200beat
20.0040.0060.0080.00914K1.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DRUGclose 22.1420-day 41.0850-day 50.76200-day 70.6822.1452w low

82.1% under the 52-week high of 123.75 on 6 Jan 2026. 52-week low 17.40 on 5 Nov 2026. Last 15 sessions, 232.1% high to low

Profile

DRUG
52-week range, 4% of the way up
17.40123.75

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

IndexRUT
Employees25
IPOMar 22, 2021
Beta-4.80
ATR, 14d4.78
Rel volume0.97
Short float10.60%
Insider own23.39%
Inst own83.54%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap218.39M
Enterprise Value1.47M
Income-17.75M
Sales0.00M
Book/sh21.99
Cash/sh22.00
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees25
IPOMar 22, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B1.01
P/C1.01
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio121.97
Current Ratio121.97
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.08
EPS next Y-6.12
EPS next Q-1.16
EPS this Y-108.64%
EPS next Y-125.12%
EPS next 5Y-
EPS past 3/5Y35.51% -35.46%
Sales past 3/5Y- -
EPS Y/Y TTM-120.28%
Sales Y/Y TTM-
EPS Q/Q67.03%
Sales Q/Q-
EarningsAug 17 BMO
EPS/Sales Surpr.86.51% -

Ownership

Insider Own23.39%
Insider Trans0.00%
Inst Own83.54%
Inst Trans2.53%
ROA-13.80%
ROE-13.93%
ROIC-8.18%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-46.10%
SMA50-56.38%
SMA200-68.68%
Trades-

Technical

Shs Outstand9.86M
Shs Float7.56M
Short Float10.60%
Short Ratio4.56
Short Interest0.80M
52W High123.75 -82.11%
52W Low17.40 27.24%
Volatility16.07% 12.72%
ATR (14)4.78
RSI (14)26.69
Beta-4.80
Rel Volume0.97
Avg Volume175.76K
Volume105,552

Performance

Perf Week16.77%
Perf Month-56.89%
Perf Quarter-71.62%
Perf Half Y-73.82%
Perf YTD-71.63%
Perf Year-62.63%
Perf 3Y1729.75%
Perf 5Y-34.50%
Perf 10Y-
Recom1.11
Target Price120.95
Prev Close22.61
Price22.14
Change %-2.08%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Oct 15, 2026InitiatedWWolfe ResearchOutperform$150+577.5%
Apr 13, 2026InitiatedJJefferiesBuy$145+554.9%
Sep 08, 2025InitiatedBBTIG ResearchBuy$72+225.2%
May 13, 2025InitiatedTTD CowenBuy
May 07, 2025InitiatedCChardan Capital MarketsBuy$80+261.3%
Jan 23, 2025InitiatedPPiper SandlerOverweight$93+320.1%
Jan 10, 2025InitiatedHH.C. WainwrightBuy$85+283.9%
Jan 10, 2025InitiatedCCantor FitzgeraldOverweight
Nov 26, 2024InitiatedRRobert W. BairdOutperform$75+238.8%

Peers

Mkt cap
TickerCompanyMkt cap
STOKStoke Therapeutics Inc1.77B
XENEXenon Pharmaceuticals Inc4.09B
PRAXPraxis Precision Medicines Inc9.75B
RAPPRapport Therapeutics Inc1.57B
OVIDOvid Therapeutics Inc528.28M
SPTXSeaport Therapeutics Inc1.12B
HELPHelus Pharma Inc695.53M
GHRSGH Research PLC1.32B
MPLTMapLight Therapeutics Inc423.43M
NMRANeumora Therapeutics Inc86.39M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cormorant Asset Management, LPFormer 10% OwnerApr 28 '26Sale89.50109,3319,785,124950,000Apr 30 04:07 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
PSILAdvisorShares Psychedelics ETFAUM: 43.26M
IWCiShares Micro-Cap ETFAUM: 1.22B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFAUM: 1.06B

News

latest 14 of 174

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-08-17-0.173-1.283-0.1740.000.006
2026Q22026-05-19-0.793-0.863-0.7950.000.007
2026Q12026-02-15-0.712-0.866-0.6990.000.006
2025Q42025-12-24-0.477-0.559-0.4140.000.006
2025Q32025-08-14-0.537-0.576-0.5350.000.006
2025Q22025-05-15-0.300-0.307-0.2920.000.006
2025Q12025-03-110.008-0.0160.0050.000.004
2024Q42024-11-27-0.119-0.429-0.1250.00-1
2022Q32022-08-13-0.852--0.8780.000.00-
2022Q22022-05-17-0.296--1.495---
2026Q4---1.165--0.009
2027Q1---1.294--0.006
2027Q2---1.468--0.006
2027Q3---1.589--0.006
2027Q4---1.908--0.006
2028Q1---2.106---1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-0.453-0.786-0.4780.00-
2025FY-1.302-1.465-1.2890.000.00
2026FY--2.717--0.00
2027FY--6.117--0.00
2028FY--7.417--0.00
2029FY--5.932--95.61
2030FY--3.752--142.47

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-145000.000.000.00
2026Q4S2026-08-174000.000.000.00
2026Q4S2026-06-073000.000.000.00
2026Q4S2026-05-204000.000.000.00
2026Q4S2026-05-184000.000.000.00
2026Q4S2026-04-153000.000.000.00
2026Q4S2026-02-164000.000.000.00
2026Q4S2026-01-054000.000.000.00
2026Q4S2025-12-243000.000.000.00
2026Q4S2025-11-113000.000.000.00
2026Q4S2025-11-103000.000.000.00
2026Q4S2025-11-093000.000.000.00
2026Q4S2025-11-083000.000.000.00
2026Q4S2025-11-073000.000.000.00

Estimate history

EPS, annual-0.046-0.279-3.811-4.741-1.469-0.478-1.272-2.0843
Period2019202020212022202320242025TTM
EPS, quarterly0.036-0.1250.005-0.292-0.535-0.414-0.699-0.795-0.176
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1.2811.2812.3673.5183.7724.5247.6369.864
Period2019202020212022202320242025MRQ
Shares, quarterly4.4644.5246.9897.0837.0857.6367.7879.8129.864
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.060.050.050.050.000.000.000.00
Gross Profit-0.06-0.05-0.05-0.05-0.000.000.000.00
Selling, General and Administrative Excl. Other28.429.892.015.4111.726.960.360.06
Research and Development23.737.930.873.719.534.990.140.03
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-28.48-9.94-2.07-5.46-11.72-6.96-0.36-0.06
Interest Expense0.020.030.010.01-0.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-17.56-8.75-2.06-5.47-11.71-6.84-0.36-0.06
Income Taxes0.190.000.000.000.000.000.000.00
Consolidated Net Income-17.75-8.75-2.06-5.47-11.71-6.84-0.36-0.06
Net Income From Continuing Operations-17.75-8.75-2.06-5.47-11.71-6.84-0.36-0.06
Net Income-17.75-8.75-2.06-5.47-11.71-6.84-0.36-0.06
EPS (Recurring)-1.81-1.27-0.48-1.47-4.74-3.81-0.28-0.05
EPS (Basic, Before Extraordinaries)-2.08-1.27-0.48-1.47-4.74-3.81-0.28-0.05
EPS (Diluted)-2.08-1.27-0.48-1.47-4.74-3.81-0.28-0.05
EBITDA-28.42-9.89-2.01-5.41-11.72-6.96-0.36-0.06
Non-Operating Income (Expense)10.931.220.020.010.010.120.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.951.880.620.850.680.560.120.00
Shares Outstanding9.867.644.523.773.522.371.281.28
Market Capitalization223.03223.035.225.5721.6414.25--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.010.010.010.010.010.020.020.01
Gross Profit-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.01
Selling, General and Administrative Excl. Other8.2411.154.934.102.362.311.150.56
Research and Development6.689.514.063.471.941.790.750.31
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-8.26-11.16-4.95-4.11-2.37-2.33-1.16-0.58
Interest Expense0.000.000.000.010.010.010.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-1.73-7.63-5.43-2.78-3.97-2.060.04-0.57
Income Taxes0.000.000.000.19-0.190.000.000.00
Consolidated Net Income-1.73-7.63-5.43-2.97-3.79-2.060.04-0.57
Net Income From Continuing Operations-1.73-7.63-5.43-2.97-3.79-2.060.04-0.57
Net Income-1.73-7.63-5.43-2.97-3.79-2.060.04-0.57
EPS (Recurring)-0.18-0.80-0.70-0.41-0.53-0.290.01-0.13
EPS (Basic, Before Extraordinaries)-0.18-0.80-0.70-0.41-0.53-0.290.01-0.13
EPS (Diluted)-0.18-0.80-0.70-0.41-0.53-0.290.01-0.13
EBITDA-8.24-11.15-4.93-4.10-2.36-2.31-1.15-0.56
Non-Operating Income (Expense)6.533.54-0.471.33-1.590.281.200.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.110.650.730.460.610.430.130.15
Shares Outstanding9.869.817.797.647.087.086.994.52
Market Capitalization223.03714.17607.71429.75184.94254.08250.285.22

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments59.594.234.998.4615.600.600.06
Short Term Receivables0.300.040.030.110.090.000.00
Inventories0.000.000.000.000.000.000.00
Other Current Assets0.710.160.020.120.130.060.00
Total Current Assets60.594.435.048.7015.820.660.06
Net Property, Plant & Equipment0.080.090.050.100.000.000.00
Total Investments and Advances0.000.000.000.000.000.000.00
Long-Term Note Receivable---0.000.030.000.06
Intangible Assets0.000.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.000.00
Total Assets60.674.525.098.8015.850.660.12
Short Term Debt Incl. Current Port. of LT Debt0.060.060.050.050.000.000.00
Accounts Payable0.000.000.000.000.000.000.00
Other Current Liabilities1.620.330.151.020.500.110.03
Total Current Liabilities1.680.390.211.070.500.110.03
Long Term Debt0.030.030.000.050.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.00
Total Liabilities1.710.420.211.120.500.110.03
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity58.974.104.887.6715.340.550.10
Total Shareholders Equity58.974.104.887.6715.340.550.10
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity58.974.104.887.6715.340.550.10
Total Liabilities & Stockholders Equity60.674.525.098.8015.850.660.12
Book Value Per Share7.720.911.292.186.480.430.08
Tangible Book Value Per Share7.720.911.292.186.480.430.07
Full-Time Employees250000--
Price to Book Ratio1.031.171.032.822.18--
Return on Assets-26.83-42.87-78.73-95.07-82.89-91.13-
Return on Equity-27.74-45.87-87.09-101.79-86.10-111.08-
Return on Invested Capital-14.83-49.89-112.00-151.63-44.59-65.30-61.71
Quick Ratio36.1011.3224.268.1131.385.822.18
Current Ratio36.1011.3224.268.1131.385.822.18

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-17.75-8.75-2.06-5.47-11.71-6.84-0.36-0.06
Depreciation0.060.050.050.050.00---
Other Funds (Non Cash)-0.512.080.620.900.510.810.120.00
Funds from Operations-18.20-6.61-1.39-4.51-11.20-6.03-0.24-0.06
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.350.400.03-0.700.570.240.020.03
Cash from Operating Activities-17.86-6.22-1.36-5.21-10.63-5.79-0.21-0.03
Capital Expenditures0.000.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock199.2461.270.661.694.0720.600.750.09
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock199.2461.270.661.694.0720.600.750.09
Proceedsfrom Stock Options199.0058.460.660.882.5320.510.750.09
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.00-0.000.000.00
Other Financing Activities Uses0.000.000.000.000.00-0.000.000.00
Cash from Financing Activities199.1761.200.601.624.0720.600.750.09
Exchange Rate Effect4.230.220.01-0.030.200.18--
Net Change in Cash185.5455.21-0.76-3.62-6.3714.990.540.06
Free Cash Flow-17.86-6.22-1.36-5.21-10.63-5.79-0.21-0.03
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments216.97221.9164.9659.5937.6638.69
Short Term Receivables0.780.820.370.300.200.16
Inventories0.000.000.000.000.000.00
Other Current Assets0.951.050.900.710.520.28
Total Current Assets218.70223.7866.2360.5938.3839.13
Net Property, Plant & Equipment0.040.050.070.080.090.11
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets218.74223.8366.3060.6738.4739.24
Short Term Debt Incl. Current Port. of LT Debt0.050.060.060.060.060.05
Accounts Payable0.000.000.000.000.000.00
Other Current Liabilities1.752.691.091.620.390.39
Total Current Liabilities1.792.751.151.680.440.44
Long Term Debt0.000.000.010.030.050.06
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities1.792.751.171.710.490.50
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity216.95221.0865.1358.9737.9838.73
Total Shareholders Equity216.95221.0865.1358.9737.9838.73
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity216.95221.0865.1358.9737.9838.73
Total Liabilities & Stockholders Equity218.74223.8366.3060.6738.4739.24
Book Value Per Share21.9922.538.367.725.365.47
Tangible Book Value Per Share21.9922.538.367.725.365.47
Full-Time Employees---25--
Price to Book Ratio1.038.7210.1111.314.786.27
Return on Assets-13.80-15.06-26.63-26.92-29.60-10.98
Return on Equity-13.93-15.24-27.03-27.82-30.04-11.27
Return on Invested Capital-0.80-3.45-8.33-5.03-9.96-5.30
Quick Ratio121.9781.4857.3736.1086.5688.27
Current Ratio121.9781.4857.3736.1086.5688.27

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.61-7.71-5.43-3.00-3.86-2.06
Depreciation0.010.010.010.010.010.02
Other Funds (Non Cash)-3.51-0.121.961.171.500.47
Funds from Operations-5.11-7.80-3.48-1.81-2.35-1.57
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.820.99-0.690.86-0.28-0.09
Cash from Operating Activities-5.92-6.81-4.17-0.95-2.63-1.66
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-1.54166.739.6224.421.32-0.77
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-1.54166.739.6224.421.32-0.77
Proceedsfrom Stock Options-1.61166.709.6224.301.22-0.88
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-1.55166.719.6024.401.31-0.79
Exchange Rate Effect4.621.02-1.03-0.38-0.52-0.04
Net Change in Cash-2.86160.934.4023.07-1.84-2.49
Free Cash Flow-5.92-6.81-4.17-0.95-2.63-1.66

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.60%0.8M7.6M129.20K
2026-10-1510.98%0.8M7.6M149.38K
2026-09-3011.68%0.9M7.6M168.64K
2026-09-1512.33%0.9M7.6M194.97K
2026-08-3111.82%0.9M7.6M285.04K
2026-08-1411.90%0.9M7.5M311.69K
2026-07-3111.85%0.9M7.5M317.14K
2026-07-1512.71%1.0M7.5M310.38K
2026-06-3012.67%1.0M7.5M288.30K
2026-06-1510.87%0.8M7.5M268.72K
2026-05-2910.64%0.8M7.6M187.04K
2026-05-159.99%0.8M7.6M158.77K
2026-04-309.47%0.8M7.9M145.23K
2026-04-158.16%0.6M8.0M136.15K
2026-03-319.84%0.7M7.2M168.24K
2026-03-137.41%0.5M7.2M175.51K
2026-02-276.83%0.5M7.2M178.39K
2026-02-136.87%0.5M7.2M187.88K
2026-01-307.77%0.5M6.8M199.60K
2026-01-158.36%0.6M6.8M207.30K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5017.1021.800.0021.7100.000.000.995-0.0180.000
call5.0014.6019.300.0012.1510.000.000.998-0.0400.000
call7.5012.1016.800.008.8090.000.000.953-0.2980.003
call10.009.6014.300.007.0930.000.000.911-0.3620.006
call12.507.1011.800.005.2850.000.000.868-0.3790.007
call15.004.609.300.004.1010.000.000.819-0.3720.009
call17.502.157.000.003.0890.000.000.762-0.3490.011
call20.001.354.902.733.0132.000.000.682-0.3000.012
call22.500.004.900.003.7580.000.000.595-0.2680.013
call25.000.004.900.954.1772.000.000.565-0.3210.014
call30.000.000.150.051.9331385.000.188-0.1000.009
call35.000.004.900.401.8432.000.000.077-0.0520.005
call40.000.004.900.402.23113.000.000.067-0.0560.005
call45.000.004.900.102.5581.000.000.060-0.0590.004
call50.000.004.900.052.84027.000.000.056-0.0620.004
call55.000.004.903.403.08822.000.000.052-0.0640.004
call60.000.004.900.243.30922.000.000.050-0.0660.004
call65.000.002.400.004.0770.000.000.107-0.1420.007
call70.000.004.900.003.6900.000.000.046-0.0690.003
call75.000.004.900.003.8570.000.000.044-0.0700.003
call80.000.004.900.004.0110.000.000.043-0.0710.003
call85.000.004.900.004.1530.000.000.042-0.0720.003
call90.000.004.900.004.2860.000.000.041-0.0730.003
put2.500.000.050.000.0000.000.00-0.004-0.0560.000
put5.000.004.900.0033.0160.000.00-0.002-0.0390.000
put7.500.004.900.0015.8230.000.00-0.046-0.2960.003
put10.000.004.900.0011.6660.000.00-0.088-0.3590.006
put12.500.004.900.009.1460.000.00-0.132-0.3750.007
put15.000.004.900.407.3121.000.00-0.180-0.3690.009
put17.500.004.901.505.84221.000.00-0.236-0.3460.011
put20.000.004.900.004.4760.000.00-0.322-0.2930.012
put22.500.004.900.003.4940.000.00-0.393-0.2630.014
put25.001.005.500.002.6070.000.00-0.438-0.3300.014
put30.006.009.306.052.3411.000.00-0.905-0.0430.006
put35.0010.6015.400.004.1690.000.00-0.923-0.0480.005
put40.0015.6020.300.004.7020.000.00-0.933-0.0520.004
put45.0020.6025.500.005.1890.000.00-0.951-0.0430.003
put50.0025.6030.503.205.5611.000.00-0.955-0.0440.003
put55.0030.6035.500.005.9120.000.00-0.958-0.0460.003
put60.0035.6040.500.006.1830.000.00-0.960-0.0460.003
put65.0040.6045.500.006.3880.000.00-0.952-0.0610.003
put70.0045.6050.5045.206.6250.000.00-0.954-0.0610.003
put75.0050.6055.500.006.9000.000.00-0.964-0.0480.003
put80.0055.6060.500.007.1230.000.00-0.965-0.0480.003
put85.0060.6065.500.007.2250.000.00-0.958-0.0630.003
put90.0065.6070.500.007.3960.000.00-0.959-0.0640.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-02SEC
2026-10-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-10-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-30SEC
2026-08-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-12SCHEDULE 13G/ASEC
2026-07-02SCHEDULE 13D/ASEC
2026-06-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-20SEC
2026-05-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-26SEC
2026-05-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-15SCHEDULE 13GSEC
2026-05-12SCHEDULE 13G/ASEC
2026-04-30SCHEDULE 13G/ASEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-02-17SCHEDULE 13G/ASEC
2026-02-17SCHEDULE 13G/ASEC
2026-02-17SCHEDULE 13G/ASEC
2026-02-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-31SEC
2026-02-06SCHEDULE 13G/ASEC
2026-01-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-09SEC
2026-01-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-07SEC
2026-01-09424B5SEC
2026-01-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-07SEC
2026-01-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-06SEC
2026-01-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-07SEC
2026-01-07FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-04009.79M1
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Jupiter Topco LLC13.78%
BlackRock, Inc.7.01%
Vivo Capital, LLC5.69%
Vestal Point Capital, LP5.57%
BRAIDWELL LP4.94%
DRIEHAUS CAPITAL MANAGEMENT LLC4.43%
BALYASNY ASSET MANAGEMENT L.P.3.53%
ADAGE CAPITAL PARTNERS GP, L.L.C.3.42%
Point72 Asset Management, L.P.3.35%
DEERFIELD MANAGEMENT COMPANY, L.P.2.89%

Funds

Fund% owned
iShares Russell 2000 ETF1.99%
Eventide Healthcare & Life Sciences Fund1.33%
BlackRock Health Sciences Opportunities Portfolio0.97%
Fidelity Small Cap Index Fund0.83%
iShares Russell 2000 Growth ETF0.71%
VANGUARD RUSSELL 2000 INDEX FUND0.43%
Driehaus Micro Cap Growth Fund0.42%
BlackRock Health Sciences Term Trust0.33%
VANGUARD U.S. MOMENTUM FACTOR ETF0.30%
iShares Micro-Cap ETF0.25%

OakChart. DRUG. Cached 15 minutes.